EV/EBITDA
-8.82
+0.41+4.44%
39 min ago
Summary
- As of February 7, 2025, RARE EV/EBITDA is -8.82, with a rise of +0.41 (+4.44%) during the most recent trading day.
- RARE EV/EBITDA is now -173.91% below its all-time high of -3.22.
Performance
RARE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RARE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +4.4% | -4.4% | -4.3% |
| 1 m1 month | -2.1% | +2.1% | +2.0% |
| 3 m3 months | +13.0% | -13.0% | -12.7% |
| 6 m6 months | -5.6% | +0.1% | -7.3% |
| ytdytd | -8.1% | +8.0% | +7.8% |
| 1 y1 year | - | - | -1.2% |
| 5 y5 years | -11.8% | +32.3% | -24.5% |
RARE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -13.8% | -9.23 | +4.4% | |
| 3 m | 3-month | -7.75 | -13.8% | -10.14 | +13.0% |
| 6 m | 6-month | -7.75 | -13.8% | -11.36 | +22.4% |
| 1 y | 1-year | -5.97 | -47.7% | -11.36 | +22.4% |
| 3 y | 3-year | -3.22 | -173.9% | -13.68 | +35.5% |
| 5 y | 5-year | -3.22 | -173.9% | -75.56 | +88.3% |
| alltime | all time | -3.22 | -173.9% | -75.56 | +88.3% |
Ultragenyx Pharmaceutical EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -8.82(+8.1%) |
| 2024 | -8.16(+65.9%) |
| 2022 | -4.92(-63.7%) |
| 2021 | -13.56(-77.9%) |
| 2020 | -61.40(+1054.1%) |
| Date | Value |
|---|---|
| 2019 | -5.32(-55.0%) |
| 2018 | -11.82(+89.7%) |
| 2017 | -6.23(-44.4%) |
| 2016 | -11.20(-61.6%) |
| 2015 | -29.16(+18.8%) |
| 2014 | -24.55 |
FAQ
- What is Ultragenyx Pharmaceutical EV/EBITDA?
- What is the all time high EV/EBITDA for Ultragenyx Pharmaceutical?
- What is RARE EV/EBITDA year-to-date change?
What is Ultragenyx Pharmaceutical EV/EBITDA?
The current EV/EBITDA of RARE is -8.82
What is the all time high EV/EBITDA for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high EV/EBITDA is -3.22
What is RARE EV/EBITDA year-to-date change?
Ultragenyx Pharmaceutical EV/EBITDA has changed by -0.66 (-8.09%) since the beginning of the year